The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis

被引:6
作者
Welsh, Silje [1 ,2 ]
Sam, Zihao [1 ,2 ]
Seenan, John Paul [2 ,3 ]
Nicholson, Gary A. [2 ,3 ]
机构
[1] Univ Edinburgh, Edinburgh Med Sch Clin Sci, Edinburgh, Midlothian, Scotland
[2] NHS Greater Glasgow & Clyde, Gen Surg & Gastroenterol Dept, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Med Sch, Glasgow, Lanark, Scotland
关键词
appendicectomy; ulcerative colitis; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL NEOPLASIA; APPENDIX; RISK; THERAPY; COLECTOMY; PREDICTORS; PROTECTS; COHORT;
D O I
10.1093/ibd/izac127
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background This updated systematic review and meta-analysis investigates the putative role of the appendix in ulcerative colitis as a therapeutic target. Methods Ovid Medline, Embase, PubMed and CENTRAL were searched with MeSH terms ("appendectomy" OR "appendicitis" OR "appendix") AND ("colitis, ulcerative") through October 2020, producing 1469 references. Thirty studies, including 118 733 patients, were included for qualitative synthesis and 11 for quantitative synthesis. Subgroup analysis was performed on timing of appendicectomy. Results are expressed as odds ratio (OR) with 95% confidence intervals (CIs). Results Appendicectomy before UC diagnosis reduces the risk of future colectomy (OR, 0.76; 95% CI, 0.65-0.89; I-2 = 5%; P = .0009). Corresponding increased risk of colorectal cancer and high-grade dysplasia are identified (OR, 2.27; 95% CI, 1.11-4.66; P = .02). Significance is lost when appendicectomy is performed after disease onset. Appendicectomy does not affect hospital admission rates (OR, 0.87; 95% CI, 0.68-1.12; I-2 = 93%; P = .27), steroid use (OR, 1.08; 95% CI, 0.78-1.49; I-2 = 36%; P = .64), immunomodulator use (OR, 1.04; 95% CI, 0.76-1.42; I-2 = 19%; P = .79), or biological therapy use (OR, 0.76; 95% CI, 0.44-1.30; I-2 = 0%; P = .32). Disease extent and risk of proximal progression are unaffected by appendicectomy. The majority (71% to 100%) of patients with refractory UC avoid colectomy following therapeutic appendicectomy at 3-year follow-up. Conclusions Prior appendicectomy reduces risk of future colectomy. A reciprocal increased risk of CRC/HGD may be due to prolonged exposure to subclinical colonic inflammation. The results warrant further research, as consideration may be put toward incorporating a history of appendicectomy into IBD surveillance guidelines. A potential role for therapeutic appendicectomy in refractory left-sided UC is also identified. Lay Summary This article was written as part of a higher degree with the University of Edinburgh. The first author received the Association of Surgeons in Training (ASiT) Edinburgh Surgery Online Bursary during the completion of the degree and this journal article. This updated systematic review finds appendicectomy before ulcerative colitis (UC) diagnosis reduces risk of future colectomy but increases the risk of colorectal malignancy. Incorporating a history of appendicectomy into IBD surveillance guidelines could be considered. A potential role for therapeutic appendicectomy in left-sided treatment refractory UC is also identified.
引用
收藏
页码:633 / 646
页数:14
相关论文
共 68 条
[1]   The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Alatab, Sudabeh ;
Sepanlou, Sadaf G. ;
Ikuta, Kevin ;
Vahedi, Homayoon ;
Bisignano, Catherine ;
Safiri, Saeid ;
Sadeghi, Anahita ;
Nixon, Molly R. ;
Abdoli, Amir ;
Abolhassani, Hassan ;
Alipour, Vahid ;
Almadi, Majid A. H. ;
Almasi-Hashiani, Amir ;
Anushiravani, Amir ;
Arabloo, Jalal ;
Atique, Suleman ;
Awasthi, Ashish ;
Badawi, Alaa ;
Baig, Atif A. A. ;
Bhala, Neeraj ;
Bijani, Ali ;
Biondi, Antonio ;
Borzi, Antonio M. ;
Burke, Kristin E. ;
Carvalho, Felix ;
Daryani, Ahmad ;
Dubey, Manisha ;
Eftekhari, Aziz ;
Fernandes, Eduarda ;
Fernandes, Joao C. ;
Fischer, Florian ;
Haj-Mirzaian, Arvin ;
Haj-Mirzaian, Arya ;
Hasanzadeh, Amir ;
Hashemian, Maryam ;
Hay, Simon, I ;
Hoang, Chi L. ;
Househ, Mowafa ;
Ilesanmi, Olayinka S. ;
Balalami, Nader Jafari ;
James, Spencer L. ;
Kengne, Andre P. ;
Malekzadeh, Masoud M. ;
Merat, Shahin ;
Meretoja, Tuomo J. ;
Mestrovic, Tomislav ;
Mirrakhimov, Erkin M. ;
Mirzaei, Hamed ;
Mohammad, Karzan A. ;
Mokdad, Ali H. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01) :17-30
[2]   Appendectomy and protection against ulcerative colitis. [J].
Andersson, RE ;
Olaison, G ;
Tysk, C ;
Ekbom, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :808-814
[3]  
[Anonymous], Systematic Review and Literature Review Software by DistillerSR
[4]   Biological therapy for ulcerative colitis [J].
Arora, Zubin ;
Shen, Bo .
GASTROENTEROLOGY REPORT, 2015, 3 (02) :103-109
[5]   Appendicectomy as a potential therapy for refractory ulcerative proctitis [J].
Bageacu, S. ;
Coatmeur, O. ;
Lemaitre, J. P. ;
Lointier, P. ;
Del Tedesco, E. ;
Phelip, J. M. ;
Roblin, X. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (02) :257-258
[6]  
Barreiro M, 2009, GASTROENTEROLOGY, V136, pA356
[7]  
Bemelman W., 2019, COLONIC SALVAGE THER
[8]  
Bolin T, 2010, GASTROENTEROLOGY, V138, pS70
[9]   Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease [J].
Bonovas, S. ;
Fiorino, G. ;
Lytras, T. ;
Nikolopoulos, G. ;
Peyrin-Biroulet, L. ;
Danese, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) :1179-1192
[10]   Guidelines for the management of inflammatory bowel disease in adults [J].
Carter, MJ ;
Lobo, AJ ;
Travis, SPL .
GUT, 2004, 53 :v1-v16